Curative immunotherapy-based strategies for non-metastatic non-small cell lung cancer
Justin J. Kuhlman, Shenduo Li, Rami Manochakian, Yanyan Lou, Yujie Zhao · 2024
Read Curative immunotherapy-based strategies for non-metastatic non-small cell lung cancer by Justin J. Kuhlman, Shenduo Li, Rami Manochakian, Yanyan Lou, Yujie Zhao (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11702264.txt.
Description
Justin Kuhlman and four co-authors review how immunotherapy is moving into curative treatment of lung cancer that has not yet spread, in this 2024 review. Checkpoint inhibitor drugs have shown clear benefit for locally advanced non-small cell lung cancer treated with surgery or with combined chemotherapy and radiation. The authors gather the key trial data, then take up the open practical questions: when around surgery the drugs should start, and how long they should run. They close by marking unmet needs and the directions trials are heading next.
Catalog record
| CREATOR | Justin J. Kuhlman, Shenduo Li, Rami Manochakian, Yanyan Lou, Yujie Zhao |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |